Huntington's disease drug: Teva Pharma settles patent dispute with Lupin, continues to litigate against Aurobindo Ruchika Sharma3 May 2022 4:05 PM ISTUnder the terms of the settlement agreement, Lupin will have a license to sell its generic product beginning April 2033, or earlier under certain...
Violation of drugs patents: Boehringer Ingelheim demands mechanisms in place Roshni Dhar26 April 2022 2:20 PM ISTDrug major Boehringer Ingelheim India has urged authorities to put in place a system that will inform patent holders whenever an application is filed...
Health Bulletin 23/April/2022 Roshni Dhar23 April 2022 5:34 PM ISTHere are the Top Health stories of the day:Foreign MBBS medicos must secure 50 percent marks in 10+2 to appear in FMGE: Delhi HCDismissing the plea by...
Violation of Drugs Patents: Boehringer Ingelheim demands authorities set mechanisms in place Ruchika Sharma21 April 2022 3:42 PM ISTA notification system would be helpful if any manufacturer files for approval with a state government and the DCGI and the patent holder is notified...
Patent Infringement: GSK moves court against Glenmark over Vilor F Medical Dialogues Team20 Nov 2021 4:51 PM ISTNew Delhi: Coming down on Glenmark Pharmaceuticals, British drug maker GlaxoSmithKline has filed a patent infringement case in the Delhi High Court...
Dr Reddys, MSN Labs launch of generic Empagliflozin may lead to court battle Farhat Nasim20 Oct 2021 2:01 PM ISTHyderabad: Taking head-on collision with Boehringer Ingelheim over blockbuster diabetes drug, two Indian pharma giants have recently launched their...
Setback to AstraZeneca: Delhi HC rejects plea against 9 pharma firms over Dapagliflozin Medical Dialogues Team26 July 2021 4:12 PM ISTNew Delhi: In a major setback to AstraZeneca and its Indian subsidiary ,the Delhi High Court has dismissed AstraZeneca's plea against nine generic...
Delhi HC restrains Natco Pharma from infringing FMC Corporation agrochemical product Medical Dialogues Team13 July 2021 5:30 PM ISTNew Delhi: In a setback to Natco Pharma, Delhi High Court has upheld an interim injunction against the drug maker filed by FMC Corporation over...
Delhi HC Restrains Firm From Infringing on MSD Diabetes Drug Sitagliptin Medical Dialogues Team8 Jun 2021 8:36 PM ISTNew Delhi: In a major relief to Merck Sharp & Dohme Corp, the Delhi High Court has barred YMS Laboratories Private Limited from infringing on...
Shilpa Medicare files patent infringement suit against Novartis over Fingolimod Medical Dialogues Team29 April 2021 11:00 AM ISTNew Delhi: In a setback to Novartis Pharmaceutical Corporation, Shilpa Pharma inc, a Shilpa Medicare subsidiary headquartered in the United States,...
Himachal drugmaker agrees to destroy infringed stock of Merck Diabetes Drug Sitagliptin Medical Dialogues Team7 April 2021 6:42 PM ISTNew Delhi: In a relief to Merck, Hariom Pharmachem has agreed to destroy the stock of infringed products of Merck's popular diabetes drug Sitagliptin,...
Pfizer pulls Dr Reddys, Aurobindo Pharma to US court over blockbuster cancer drug Ibrance Ruchika Sharma17 Nov 2020 5:54 PM ISTPfizer in its petition stated that Aurobindo Pharma and Dr Reddys have submitted ANDA to the USFDA seeking approval to engage in commercial...
